[1. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.10.1056/NEJM199904153401501]Search in Google Scholar
[2. Keys HM, Bundy BN, Stehman FB, Mudersprach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61.10.1056/NEJM199904153401503]Search in Google Scholar
[3. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-48.10.1200/JCO.1999.17.5.1339]Search in Google Scholar
[4. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 8: 358(9284): 781-6.10.1016/S0140-6736(01)05965-7]Search in Google Scholar
[5. Vale C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-12.10.1200/JCO.2008.16.4368264510019001332]Search in Google Scholar
[6. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Haie-Meder C, editors. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002. p. 301-63.]Search in Google Scholar
[7. Pötter R, Van Limbergen E, Wambersie A. Reporting in brachytherapy: dose and volume specification. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002. p. 155-215.]Search in Google Scholar
[8. ICRU, International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU Report 38. Bethesda, MD: ICRU; 1985.]Search in Google Scholar
[9. Massey JB, Pointon RS, Wilkinson JM. The Manchester System and the BCRU recommendations for brachytherapy source specification. Br J Radiol 1985; 58: 911-3.10.1259/0007-1285-58-693-9113842294]Search in Google Scholar
[10. Guedea F, Ellison T, Venselaar J, Borras JP, Hoskin P, Poetter R, et al. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. Radiother Oncol 2007; 82: 50-4.10.1016/j.radonc.2006.11.01117150270]Search in Google Scholar
[11. Guedea F, Ellison T, Hoskin P, Hellebust TP, Didier Peiffert D, Londres B, et al. Patterns of care of brachytherapy in Europe: updated results. RadiotherOncol 2010; 97: 514-20.10.1016/j.radonc.2010.09.00920950878]Search in Google Scholar
[12. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45.10.1016/j.radonc.2004.12.01515763303]Search in Google Scholar
[13. Pötter R, Haie-Meder C, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.10.1016/j.radonc.2005.11.01416403584]Search in Google Scholar
[14. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Wambersie A, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003; 68: 269-76.10.1016/S0167-8140(03)00189-0]Search in Google Scholar
[15. Pötter R, VanLimbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001; 58: 11-8.10.1016/S0167-8140(00)00266-8]Search in Google Scholar
[16. Pötter R. Modern imaging in brachytherapy. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002. p. 123-51.]Search in Google Scholar
[17. Barillot I, Horiot JC, Maingon P, Truc G, Chaplain G, Comte J, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies. Int J RadiatOncol Biol Phys 2000; 48: 189-200.10.1016/S0360-3016(00)00556-3]Search in Google Scholar
[18. Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999; 44: 855-66.10.1016/S0360-3016(99)00111-X]Search in Google Scholar
[19. Kovalic JJ, Perez CA, Grigsby PW, Lockett MA. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991; 21: 905-10.10.1016/0360-3016(91)90728-M]Search in Google Scholar
[20. Perez CA, Fox S, Lockett MA, Grigsby PW, Camel HM, Galakatos A, et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 1991; 21: 885-98.10.1016/0360-3016(91)90726-K]Search in Google Scholar
[21. Roeske JC, Mundt AJ, Halpern H, Sweeney P, Sutton H, Powers C, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: A dosimetric analysis. Int J Radiat Oncol Biol Phys 1997; 37: 351-8.10.1016/S0360-3016(96)00490-7]Search in Google Scholar
[22. Chen SW, Liang JA, Yeh LS, Yang SN, Shiau AC, Lin FJ. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2004; 60: 663-71.10.1016/j.ijrobp.2004.05.028]Search in Google Scholar
[23. Ogino I, Kitamura T, Okamoto N, Yamasita K, Aikawa Y, Okajima H, et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 1995; 31: 725-34.10.1016/0360-3016(94)00547-8]Search in Google Scholar
[24. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int JRadiat Oncol Biol Phys 2001; 50: 1123-35.10.1016/S0360-3016(01)01533-4]Search in Google Scholar
[25. Kim HJ, Kim S, Ha SW, Wu HG. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer? Tumori 2008; 94: 327-32.]Search in Google Scholar
[26. Petric P, Hudej R, Marolt-Mušič M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachytherapy 2009; 1: 163-9.]Search in Google Scholar
[27. Petric P, Hudej R, Rogelj P, Blas M, Segedin B, Zobec Logar HB, Dimopoulos JCA. Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy. Radiol Oncol 2012; 46: 242-51.10.2478/v10019-012-0023-1]Search in Google Scholar
[28. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.10.1016/0360-3016(95)00060-C]Search in Google Scholar
[29. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995; 31: 1049-91.10.1016/0360-3016(95)90159-0]Search in Google Scholar
[30. Baškovič M, Cerar O, Kaučič M, Kocijan A, Kovačič J, Kuhelj J, et al. [Guidelines for the treatment of the gynaecological malignancies]. [Slovenian]. Ljubljana: Zveza slovenskih društev za boj proti raku; 1992.]Search in Google Scholar
[31. Baškovič M, Bebar S, Cerar O, Fras AP, Kragelj B, Robič V, et al. [Gynaecological malignancies. Guidelines for the treatment at the Institute of Oncology Ljubljana and Gynaecological Clinic of the University Medical Centre Ljubljana]. [Slovenian]. 2nd revisioned edition. Ljubljana: Zveza slovenskih društev za boj proti raku; 2001.]Search in Google Scholar
[32. Stržinar V, Baškovič M, Bebar S, Cerar O, Fras AP, Koritnik K, et al. [Gynaecological malignancies. Guidelines for the treatment at the Institute of Oncology Ljubljana and Gynaecological Clinic of the University Medical Centre Ljubljana]. [Slovenian]. 3rd revisioned edition. Ljubljana: Zveza slovenskih društev za boj proti raku, 2002.]Search in Google Scholar
[33. Perez Ca, Breaux S, Bedwinek JM, Madoc-Jones H, Camel HM, Purdy JA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984; 54: 235-46.]Search in Google Scholar
[34. Fletcher GH, Hamburger AD. Female pelvis. Squamous cel carcinoma of the uterine cervix. In: Fletcher GH, editor. Textbook of radiotherapy. 3rd edition. Philadelphia: Lea and Febiger; 1980. p. 720-89.]Search in Google Scholar
[35. Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 2000; 4: 159-72.10.1016/S1278-3218(00)88900-3]Search in Google Scholar
[36. Horiot JC, Pigneux J, Pourquier H. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988; 14: 605-11.10.1016/0360-3016(88)90080-6]Search in Google Scholar
[37. Pernot M, Hoffstetter S, Peiffert D, Carolus JM, Guillemin F, Verhaeghe JL, et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment. Bull Cancer 1995; 82: 568-81.]Search in Google Scholar
[38. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998; 41: 307-17. Erratum in: Int J Radiat Oncol BiolPhys 1999; 45: 1093.]Search in Google Scholar
[39. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997; 38: 969-78.10.1016/S0360-3016(97)00145-4]Search in Google Scholar
[40. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J RadiatOncol Biol Phys 2001; 50: 1123-35.10.1016/S0360-3016(01)01533-4]Search in Google Scholar
[41. Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys 2003; 55: 695-706.10.1016/S0360-3016(02)03939-1]Search in Google Scholar
[42. Lorvidhaya V, Tonusin A, Changwiwit W, Chitapanarux I, Srisomboon J, Wanwilairat S, et al. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients. Int J Radiat Oncol BiolPhys 2000; 46: 1185-91.10.1016/S0360-3016(99)00383-1]Search in Google Scholar
[43. Dimopolus J, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 2006; 64: 1380-8.10.1016/j.ijrobp.2005.10.01716580496]Search in Google Scholar
[44. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. IntJ Radiat Oncol Biol Phys 2006; 65: 624-30.10.1016/j.ijrobp.2006.01.036]Search in Google Scholar
[45. Erickson B, Grossheim L, Mai J. Imaging the nondisplaced rectosigmoid during HDR brachytherapy for cervical cancer can alter dose specification. [Abstract]. Radiother Oncology 2004; 71(Suppl 2): S9.10.1016/S0167-8140(04)80072-0]Search in Google Scholar
[46. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU referencepoint estimates of radiation doses delivered to bladder and rectum during itracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62: 131-7.10.1016/j.ijrobp.2004.09.059]Search in Google Scholar
[47. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62: 901-11.10.1016/j.ijrobp.2005.02.040]Search in Google Scholar
[48. Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 2006; 5: 223-9.10.1016/j.brachy.2006.09.001]Search in Google Scholar
[49. Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat OncolBiol Phys 2003; 57: 1010-8.10.1016/S0360-3016(03)00721-1]Search in Google Scholar
[50. Morris M, Eifel PJ, Lu J, Grigsby P, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New Engl J Med 1999; 340: 1137-43.10.1056/NEJM199904153401501]Search in Google Scholar
[51. Haie-Meder C, de Crevoisier R, Bruna A, Lhommé C, Pautier P, Morice P, et al. Concomitant chemoradiation in patients with cervix cancer. Bull Cancer 2005; 92: 1032-8.]Search in Google Scholar
[52. Heinzelmann F, Henke G, von Grafenstein M, Weidner M, Paulsen F, Staebler A, et al. Adjuvant radiochemotherapy in patients with locally advanced highrisk cervical cancer. Strahlenther Onkol 2012; 188: 568-75.10.1007/s00066-012-0123-2]Search in Google Scholar
[53. Kim JY, Kim JY, Kim JH, Yoon MS, Kim J, Kim YS. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases. Int J Radiat Oncol Biol Phys 2012; 84: 741-7.10.1016/j.ijrobp.2012.01.070]Search in Google Scholar
[54. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32: 1275-88.10.1016/0360-3016(95)00220-S]Search in Google Scholar